Background. Efficient islet isolation represents a necessary requirement for successful islet transplantation as a treatment for type 1 diabetes. The choice of collagenase for pancreas digestion is critical for the isolation outcome, and Liberase™ is the most widely used enzyme, although large intra-batched variability in activity and efficiency has been observed. Methods. The aim of this study was to characterize Liberase™ components and their relative role in pancreas digestion. Liberase batches were characterized by microelectrophoresis. Results. By means of microelectrophoresis, we identified three main proteins each with different prevalences between batches. Two proteins were found to correspond to class I (CI) and one to class II (CII) collagenase. In a series of 163 islet isolations, we observed that the CII correlated with islet yield (PϽ0.001) and digestion time (PϽ0.001); additionally, CI directly correlated with purity (Pϭ0.028). Finally, when CII and one of the CI isoforms were Ͼ50 percentile, 15 of 36 preparations were transplanted, with 27 of 127 transplanted in the other cases (Pϭ0.013). Conclusion. These results represent an important step toward the characterization of enzymes, with the final aim of identifying key components for a standardized product.
A standardization of human islet isolation that produces a sufficient number of good-quality islets in a reproducible way is an essential requisite for a successful clinical transplant program (1) . An optimization of isolation techniques would permit an increased number of transplants and a reduction of costs, which are important requisites for securing reimbursement for this procedure from health insurance providers and national health systems.
To date, a real standardized procedure has not been possible because of the fact that one of the crucial steps of isolation, organ digestion, does not yield a standardized product. Second, the enzyme used, collagenase, presents different characteristics from batch to batch, and from vial to vial, because of problems of instability (2, 3) . Furthermore, there are no precise parameters for the evaluation of enzymatic efficacy before its use; therefore, it is necessary to experiment with an enzyme batch many times before determining its suitability. Enzyme activity per se, commonly available for each batch, is not considered a useful parameter for the selection of successful batches and therefore other parameters or methods of analyses are expected at this purpose (4) .
The introduction of purified products has not solved that problem (5) (6) , because the proposed enzymes are always obtained from Clostridium histolyticum cultures and remain different from batch to batch as well. A significant variability of enzyme activity was recently described not only between Liberase batches but also between vials of the same batch (3) . The first experiments with a type of recombinant collagenase have not provided additional information (7) . In fact, with the data now available, standardization remains a difficult challenge, because the composition of efficient enzyme blends, especially for human pancreas digestion, is not yet well defined (8) .
Different isoforms of collagenase, identified by the Greek letters (␣, ␤, ␥, ␦, , ), belong to two classes (CI and CII) (9 -12) . Concerning the rat pancreas digestion, it has been reported that the CII is the most efficient at digesting exocrine tissue, whereas CI increases the digestion rate (13, 14) ; therefore, an appropriate mix of CI and CII has been proposed to optimize islet isolation (15) (16) (17) (18) . In the early stages of digestion, neutral proteases also are needed, but in excessive amounts these can destroy islet integrity (19 -21) . A protocol for using CI and CII together with neutral proteases for the human pancreas digestion has been proposed (22) , but nothing is known about the role of the different isoforms of collagenase within the same class.
MATERIALS AND METHODS

Islet Isolation
Islets were isolated using the automated method described by Ricordi (23) and purified as previously described (24) . The enzyme used for isolation was Liberase™ (0.5-1.4 mg/mL; Roche, Indianapolis, IN). In 350 mL of Hank's solution, an amount of enzymes ranging from 175 to 500 mg (related to the trimmed pancreas weight, about 4 mg of enzyme per gram of pancreas) was gentle dissolved. The enzyme concentration was further reduced (up to 50%) if the donor was younger than 20 years old. All preparations were submitted to the purification (for transplantation or for research purpose) with the exception of those in which digestion completely failed (completely destroyed islets or undigested tissue). In these cases, the number of isolated islets was reported to be 0, as well as in those isolations in which the purification completely failed and all the tissue was discharged. The final number of isolated islets considered in the analyses and their corresponding purity were calculated, including all gradient layers with islets up to remaining under 10 mL of total tissue volume (as in the case of a possible islet transplantation). Islet cell viability was estimated by propidium iodide staining and insulin responsiveness to glucose by static incubation, as previously described (4).
Bacterial Collagenases
Liberase™ HI (15 batches) from C. histolyticum used in human isolation were analyzed. The different sample batches were collected during a period of 3 years. Each aliquot of Liberase™ was collected before enzyme reconstitution from a new vial, after proper equilibration on ice and mixing of the vial contents (3). Four samples were reconstituted from each batch with 10 mM EDTA solution (Sigma-Aldrich Corporation, S. Louis, MO) on ice and quickly loaded for characterization using different analyses. A protocol for the preparation of enzyme samples was tested and standardized to prevent uncontrolled degradation prior to biochemical analysis and to be used in isolations. The samples' final concentration was 1 mg/ml for the Protein 200 Plus Assay (Agilent Technologies, Palo Alto, CA; milligram of powder mass provided by the manufacture).
The samples from lyophilized separated components, Collagenase Class I, Collagenase Class II, and Thermolysin (Roche, Indianapolis, IN), were similarly collected and reconstituted. Activity is expressed in Wunsch units (U/mg or U/vial) for collagenase class II and Liberase, in Caseinase units (U/mg or U/vial) for neutral proteases. These values were obtained from the Roche's Certificate of Analysis.
Microelectrophoresis Analysis
The regarding peaks (migration time, molecular weight, peak area, % total) is generated for each sample. The three main peaks were defined G, D, and B. The proportion of the peak area of a specific collagenase fraction relative to the sum of all peaks was expressed as a ratio, and reported as an "Index" (3) . To evaluate the intra-assay coefficient of variations (%CV), samples from the same vial were analyzed on the same microchip. The CV values were 2.6%, 5.1%, and 1.7% for peaks G, D, and B respectively. To evaluate differences between vials of the same batch, samples from different vials were tested on the same microchip (intralot %CV). The CV values were 2.4%, 0.7%, and 5.3% for peaks G, D, and B, respectively. Samples from different vials of the same lot were analyzed using different microchips at different times: 6.6%, 6.7%, 5.5% were the CV values founded for peaks G, D, and B respectively.
Islet Transplantation
Transplantation was performed between 2 and 72 hr after isolation. Preparations were considered adequate for transplantation according to the following criteria: (1) NE (Ͼ5,000 per kg body weight); (2) purity Ͼ20% (dithizonestaining determination of islet/total mass); and (3) islet sterility and cell viability Ͼ70% analyzed by propidium iodide (4) . Purification was defined to be 20% or greater because, in our experience, this limit maintains the tissue volume for transplant to less than 10 mL. A total of 42 islet preparations were transplanted into HLA-mismatched recipients affected by type 1 diabetes as previously described (4). Recipients gave informed consent and our investigations were approved by the responsible ethics committee (institutional review board). Studies were conducted in accordance with the Declaration of Helsinki as revised in 2000 (http://www.wma. net/e/policy/b3.htm).
Statistical Analysis
Data were collected from 163 performed with Liberase™. Isolations were not consecutive: procedures using collagenase type P were excluded from the analyses.
Parameters to qualify Liberase components were as follows:
• Isolation outcomes in terms of the total number of islets expressed as final NE (the absolute number corrected for coefficients based on islet volume), digestion time and purity. Final NE was preferred to prepurification NE. The purification method in this panel of isolations was the same and considering final NE instead of prepurification, we included the possible interference of enzyme also on purification.
• Islet cell viability (as percentage of live cells after propidium iodide staining) and insulin responsiveness to glucose, as secretion index (the ratio between basal and stimulated insulin secretion) as previously described (4).
• Decision whether or not to transplant the preparation. Islet preparation is defined suitable for the transplant not only on the basis of the islet number, but also on cell viability and purity (4). Therefore, this represents an overall and indirect parameter of islet preparation quality.
• Transplantation outcome in terms of posttransplant cpeptide levels and exogenous insulin requirement 1 week and 1 month after transplantation. Our recipients often received 2 or more preparations simultaneously or in subsequent transplantation. Also, immunosuppressive treatment should vary in different patients. Therefore, the number of transplants available for this analysis (single islet preparation transplantation) was limited to 10 patients, with at least 1 month follow-up and similar immunosuppressive treatment (Edmonton protocol, 4).
Variables did not show a Gaussian distribution, and a nonparametric analysis was performed. Where both variables were ordinal values, correlations were performed using the Spearman rank correlation test and expressed as Spearman's correlation coefficient. All comparisons are 2 tailed. When variables were nominal values, a 2 -square test was used and a P value lower than 0.05 was considered to be statistically significant. Activity is expressed in Wunsch units (U/mg) and neutral proteases in Caseinase units (U/mg). The prevalence of the peak area of a specific collagenase fraction, relative to the sum of all peaks, was expressed as a ratio and reported as "Index."
a This batch did not contained neutral protease.
RESULTS
Analysis of Protein Content in Liberase™ Batches by Electrophoresis
Enzyme blends were first studied by microelectrophoresis. Unexpectedly, differently from that reported by the Roche data sheet for Liberase™, and similarly to that previously reported by Lakey (3), more than two peaks appeared from the analyses of batches. All Liberase™ batches showed three main peaks (G, D, B) and one minor one (p) (see Fig. 1a for the profile of two representative batches of those included in the study). The molecular weight of peaks p, G, D, and B were 34Ϯ1, 115Ϯ1, 127Ϯ1, and 131Ϯ1 kDa, respectively (values expressed as the mean of different batchesϮstandard deviation). The absolute values of peaks depended strictly on the amount of enzyme weighed, which might be subjected to slight variations between different experiments. Therefore, each peak was expressed as an Index (see Material and Methods section). Other small peaks (usually lower than 5%) irregularly present in different batches, were considered as "remnants." Index values of remnants are inversely correlated with CII index values (PϽ0.001, rϭϪ0.656). Liberase™ batches differ in terms of proportion of each peak (Table 1) . Peak B and peak G significantly and inversely correlate (PϽ0.001, rϭϪ0.991, Fig. 1b) , suggesting that the smaller protein (peak G) could be derived from the larger one (peak B).
To identify the main peaks, we also performed a microelectrophoresis on the separate fractions produced by Roche. In Figure 2a -c, the profiles of the separated components Collagenase Class I (CI), Collagenase Class II (CII), and neutral protease (Thermolysin) are shown and compared with a Liberase™ profile. CII enzyme was overlapping with peak D (molecular weight 128Ϯ2 kDa, Fig. 2a) , CI with peak B (molecular weight 131Ϯ1 kDa), and G (115Ϯ1 kDa; Fig. 2b ). Other small peaks with molecular weight Ͼ34 kDa, irregularly present in different batches (10 of 15 batches, remnants), were present only in vials containing CII collagenase (Fig. 2a) . Thermolysin profile showed few small peaks; that with the greatest proportion value (molecular weight 34Ϯ1) was overlapping with peak p (Fig. 2c) .
Correlation Between Peaks and Isolation Outcome
The number of samples was insufficient to allow a direct comparison among characteristics and results achieved using different Liberase lots (see Table 2 ). Therefore values of CI, CII, remnants, and protease peaks of different Liberase™ batches were pooled together and correlated with some representative parameters of isolation outcome: NE, digestion time, purity.
In these analysis NE directly and significantly correlated with CII (PϽ0.001, rϭ0.305, Fig. 3a) and inversely, near to the significance, with remnants (Pϭ0.090, rϭϪ0.133). Digestion time inversely correlated with CII (significance PϽ0.001, rϭϪ0.502) and directly with remnants (Pϭ0.001, rϭ0.266). The purity of preparations inversely and significantly correlated with CI (peak G) (Pϭ0.024, rϭϪ0.265) and directly with CI (peak B) (Pϭ0.028, rϭ0.260, Fig. 3b) . No correlations were observed between protease peak values and isolation outcome (data not shown). As previously reported (4) there is a large dispersion of the data (and therefore a low "r" value) and this was expected according to the evidence that many variables are affecting human islet isolation yield. Because of the limited number of cases (nϭ163) and to the large number of variables affecting islet isolation (nϭ32 in our previous study, plus these new 4 variables) we were un- able to apply a proper multivariate analysis on these data. In a previous multivariate analysis on more than 400 isolations, we found that the activity/mg of collagenase corrected for the total mg of enzyme used in each isolation (total activity) strictly correlated with the number of isolated islets (4) . In the present study we found that when CII is similarly corrected for the mg used in each isolation, it strictly correlates with total activity (PϽ0.001, rϭ0.796).
We previously proposed as threshold to define the success of islet isolation a procedure able to achieve islet yield Ͼ250,000 (equivalent islet) and with Ͼ20% of purity (4). Accordingly, isolations were divided in two groups: successful and unsuccessful. A significant difference was observed between CII values of enzymes used in successful and unsuccessful islet isolation (Pϭ0.006, Fig. 3c ). The results of statistical analyses did not change if only batches used more than three times were included in the study.
We observed no statistical correlations between CI or CII peak values and islet cell viability or insulin responsiveness to glucose (data not shown). However, the value of these statistical analyses was probably insufficient due to the poor number of cases available compare to the large dispersion of the data observed.
Predictive Role of Collagenase Fractions Versus Transplantation
High number of isolated islets, together with good islet purity and quality, are taken into account in order to define an islet preparation's suitability for transplantation. We verified the association of each component of Liberase™ with the decision as to whether or not to transplant a preparation. In isolations using a CII peak value Ն50 percentile, 33 out of 98 were transplanted, and when values were Ͻ50 percentile, 9 of 65 were transplanted ( 2 -test, Pϭ0.005). Considering that the purity of preparations, together with NE, is a prerequisite for islet transplantation, an additional criterion was introduced due to the suggested positive role of CI peak B on purification. In isolation using CII peak value Ն50 percentile and CI peak B value Ն50 percentile, 15 out of 36 were transplanted and in the remaining cases, 27 out of 127 were transplanted ( 2 -test, Pϭ0.013). From Figure 4 , it appears evident that the highest values of CII and CI peak B correspond neither to the highest islet yield nor to the highest number of the transplanted islet preparations. Accordingly if CII peak index is limited to 0.294 -0.315 and CI peak B to 0.20 -0.35. (and as a consequence, the remaining enzyme, CI peak G in the range of 0.25-0.40), 13 out 22 islet preparations were transplanted vs. 29 of 141 islet preparations in the other cases (PϽ0.001).
In recipients receiving islet transplantation c-peptide values 1 week after transplantation correlated with CII peak values (Pϭ0.041, rϭ0.652, nϭ10) and NE (Pϭ0.003, rϭ0.830, nϭ10). No relationships were observed between CI peak B or peak G values with one week graft function. No correlation was found one month after transplantation between in vivo islet graft and Liberase peak values (data not shown).
DISCUSSION
The available information concerning the characteristics and composition of collagenase batches that are effective in the digestion of human pancreas for islet transplants is scarce and incomplete. Data achieved in animal model of pancreas digestion should not applied without criticisms in human pancreas where the clinical condition of the donors and therefore of pancreas heavily interfere with digestion success rate. In this work, we evaluated the components of Liberase™ blend enzyme and their functional role in digestion of human pancreas. This information represents the real basis for a further standardization of the procedures. The issue of standardization of the procedures is not only technical. The discontinuity of isolation success is one of the most important factors that limit the clinical applicability of islet transplantation. Discontinuous isolation results means in fact unpredictable costs of procedures and high variability of islet quality and, finally, the impossibility to perform large studies aimed at improving graft function. We observed that collagenase class II was shown to be the most important enzyme for successful islet yield, thus confirming in human pancreas digestion what was demonstrated in animal model of pancreatic isolation (16) . Indeed this is the only class whose index values within the enzyme blend directly correlates with the number of isolated islets. Thus, CII is associated also with the decision as to whether or not to transplant a preparation or not. This was quite an unexpected result, because of the limited range of variability (28 -35%) between different batches, as previously reported (3). Considering the direct correlation between NE and the CII proportion in a vial, it would be expected that the highest islet yield as well as the highest number of transplanted preparations would be obtained with the highest CII values. From Figure 3 and Figure 4 , it appears that this does not apply as the best results in terms of transplant occur with 0.294 -0.315 CII index values, a very narrow range.
The purified CII fraction collagenase shows some protein components present in small amounts (about 20% of enzyme blend), and absent in CI fraction collagenase. The presence of these proteins is inversely correlated with the presence of CII collagenase (PϽ0.001, rϭϪ0.656), which suggests that they may result from its degradation. The proportion of fragments seems to have a negative role in the isolation process (although the results are not statistically significant) thus suggesting that the quality and the purity of CII collagenase should be further improved.
It is clear that the success of isolation with regard to number of isolated islets depends on many variables, including donor characteristics and isolation procedures (4). Therefore one component of enzyme should not determine per se the fate of isolation. This appears also by the low value (rϭ0.305), albeit statistically significant, of the correlation between collagenase class II index and number of isolated islets in our retrospective analysis. Correct analyses of an eventual association between variables of isolation should be multivariate in a large number of cases, and this was not the case of this study, conducted on 163 isolations. In a recent retrospective multivariate analysis on 32 variables conducted on more than 400 isolations, we demonstrated that the collagenase activity, normalized to the amount of the enzyme used in the isolation (total activity), is one of the most important variables associated with the number of islets obtained (4) . CII proportion similarly normalized to the milligram of enzyme used in each isolation, strictly correlated with the total activity with rϭ0.796. Therefore, these two parameters appear concordant, allowing us to hypothesize that the relation between CII enzyme and the number of isolated islets observed may be significant also in a multivariate analysis on a large number of isolations although, of course, this should be further confirmed.
The increased islet yield and purity achieved with an optimal collagenase blend could be of relatively minor relevance if associated with a reduced islet function or survival. No correlation was observed between enzyme characteristics and islet viability and insulin secretion, but the large data dispersion at this regard and the poor number of cases available for this statistics limited the value of the analyses. We used 2 additional indirect parameters for evaluation of the quality of isolated islets: the suitability of an islet preparation for transplantation and in vivo graft function. Islet preparation is usually defined transplantable if it is adequate in terms of islet mass, viability and purity. Therefore, it should be considered per se an overall indirect parameter of the quality, and this parameter was associated with high CII index values, too. In vivo graft function should be not recognized as an appropriate parameter for our study, being that in vivo graft function involves too many variables, although-also in this case-a significant correlation was observed between CII and early graft function. At this regard, we do not believe CII can directly affect in vivo graft function, or at least the role of CII in affecting graft function should be secondary to the larger transplanted islet mass made available using a successful enzyme.
CI collagenase, another essential component of a blend enzyme designated to digest human pancreas, increases digestion rate as reported (16) . In our blend enzyme for islet isolation we identified two different components of CI collagenase (designated as peak B and G), which are inversely correlated. Although neither of these correlates with the number of isolated islets, peak B correlates directly with the purity of the preparation. It was already reported that enzymes used for pancreas digestion affected islet purification (21) (22) . Mechanisms should include the duration of digestion (and therefore of warm ischemia cell exposure), cell death, incomplete tissue digestion that collectively could contribute to exocrine cell degranulation and damage resulting in variable purification of islet preparation. However, the best results concerning the number of isolated islets and suitability of the preparation for transplant are obtained from a mixture of CI components. From this point of view, our conclusion differs from that reported by Lakey on the analysis of Liberase™ batch by highperformance liquid chromatography (3, 25) . In fact, Lakey describes two components of CI collagenase, of which only one was associated (in a small number of cases) with isolation success (3). It should be noted that Lakey et al. had the possibility of using batch enzymes containing only one component of class I collagenase (3, 22) . We expect in the future to test batches with similar characteristics in our laboratory.
From our analyses, it appeared that the small differences in neutral proteases content between different Liberase batches failed to significantly affect pancreas digestion outcome, differently from what it was recently reported (25) . These enzymes are considered important in the early steps of digestion (21) and the composition and content of neutral protease present in our Liberase batches appeared to be adequate for a successful digestion. Further studies should also be necessary to fully analyze the molecular structure of these enzymes.
We confirmed differences between vials as reported by Lakey, although to a lesser extent (3) . In this regard, we did not consider mass and enzyme activity changes in each vial, thus probably underestimating the real variability among vials. The microelectrophoresis analysis appears simple and reproducible and could therefore be applied to a selection of successful batches for the isolation. In fact, compared with high-performance liquid chromatography, it is quicker, describing enzymatic blend composition in few minutes.
In conclusion, the significance of this study lies in the fact that it represents the characterization of the components of blended enzymes designated for human isolations. This represents a first step toward the production of enzymes using recombinant techniques, the only means of guaranteeing continuous and reproducible isolation results. In addition the standardization of enzymes for digestion of human pancreas should promote the digestion success rate of other tissue. However, a more standardized production (3) capable of guaranteeing the stability and reproducibility of the enzyme for isolation purpose is now needed. 
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